Literature DB >> 30835028

Disease Burden of Hepatocellular Carcinoma: A Global Perspective.

Mehmet Sayiner1,2, Pegah Golabi2, Zobair M Younossi3,4.   

Abstract

Liver cancer is one of the leading causes of cancer-related mortality around the world. Hepatocellular carcinoma (HCC) is the primary cancer of the liver, accounting for the majority of liver cancers. The risk factors associated with HCC include chronic infections with HBV and HCV, alcoholic liver disease, and nonalcoholic fatty liver disease. Additionally, male patients have higher risk for than females, and the risk increases with older age. Mortality rates for HCC parallel its increasing incidence rates. In this context, incidence rate for HCC shows geographic variations in different parts of the world and is heavily affected by regional differences in risk factor for liver disease. The highest incidence rates for HCC are observed in Asia and Africa, while Europe and North America have lower rates. In fact, HBV is still regarded as the leading cause of HCC globally, while HCV is the most common cause of HCC in the USA. Recently, it has been suggested that HCC cases related to nonalcoholic fatty liver disease is on the rise, while the proportion of HCC attributed to alcoholic liver disease remains stable.

Entities:  

Keywords:  Epidemiology; Hepatitis B; Hepatitis C; Hepatocellular carcinoma

Mesh:

Year:  2019        PMID: 30835028     DOI: 10.1007/s10620-019-05537-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  82 in total

Review 1.  Health disparities in liver disease in sub-Saharan Africa.

Authors:  C Wendy Spearman; Mark W Sonderup
Journal:  Liver Int       Date:  2015-06-26       Impact factor: 5.828

2.  Non-alcoholic fatty liver disease-related hepatocellular carcinoma: a sleeping tiger in the Asia Pacific.

Authors:  Roslyn Vongsuvanh; David van der Poorten; Jacob George
Journal:  Hepatol Int       Date:  2013-07-31       Impact factor: 6.047

3.  Epidemiology of hepatocellular carcinoma in Japan.

Authors:  Takeji Umemura; Tetsuya Ichijo; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

4.  Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.

Authors:  Zobair Younossi; Maria Stepanova; Janus P Ong; Ira M Jacobson; Elisabetta Bugianesi; Ajay Duseja; Yuichiro Eguchi; Vincent W Wong; Francesco Negro; Yusuf Yilmaz; Manuel Romero-Gomez; Jacob George; Aijaz Ahmed; Robert Wong; Issah Younossi; Mariam Ziayee; Arian Afendy
Journal:  Clin Gastroenterol Hepatol       Date:  2018-06-14       Impact factor: 11.382

Review 5.  Global epidemiology and genotype distribution of the hepatitis C virus infection.

Authors:  Erin Gower; Chris Estes; Sarah Blach; Kathryn Razavi-Shearer; Homie Razavi
Journal:  J Hepatol       Date:  2014-07-30       Impact factor: 25.083

6.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

7.  Cancer incidence and cancer control in Mongolia: Results from the National Cancer Registry 2008-12.

Authors:  Tuvshinjargal Chimed; Tuvshingerel Sandagdorj; Ariana Znaor; Mathieu Laversanne; Badamsuren Tseveen; Purevsuren Genden; Freddie Bray
Journal:  Int J Cancer       Date:  2016-10-24       Impact factor: 7.396

8.  Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium.

Authors:  Ju Dong Yang; Essa A Mohamed; Ashraf O Abdel Aziz; Hend I Shousha; Mohamed B Hashem; Mohamed M Nabeel; Ahmed H Abdelmaksoud; Tamer M Elbaz; Mary Y Afihene; Babatunde M Duduyemi; Joshua P Ayawin; Adam Gyedu; Marie-Jeanne Lohouès-Kouacou; Antonin W Ndjitoyap Ndam; Ehab F Moustafa; Sahar M Hassany; Abdelmajeed M Moussa; Rose A Ugiagbe; Casimir E Omuemu; Richard Anthony; Dennis Palmer; Albert F Nyanga; Abraham O Malu; Solomon Obekpa; Abdelmounem E Abdo; Awatif I Siddig; Hatim M Y Mudawi; Uchenna Okonkwo; Mbang Kooffreh-Ada; Yaw A Awuku; Yvonne A Nartey; Elizabeth T Abbew; Nana A Awuku; Jesse A Otegbayo; Kolawole O Akande; Hailemichael M Desalegn; Abidemi E Omonisi; Akande O Ajayi; Edith N Okeke; Mary J Duguru; Pantong M Davwar; Michael C Okorie; Shettima Mustapha; Jose D Debes; Ponsiano Ocama; Olufunmilayo A Lesi; Emuobor Odeghe; Ruth Bello; Charles Onyekwere; Francis Ekere; Rufina Igetei; Mitchell A Mah'moud; Benyam Addissie; Hawa M Ali; Gregory J Gores; Mark D Topazian; Lewis R Roberts
Journal:  Lancet Gastroenterol Hepatol       Date:  2016-12-03

9.  Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.

Authors:  J West; H Wood; R F A Logan; M Quinn; G P Aithal
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

10.  The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.

Authors:  Tomi Akinyemiju; Semaw Abera; Muktar Ahmed; Noore Alam; Mulubirhan Assefa Alemayohu; Christine Allen; Rajaa Al-Raddadi; Nelson Alvis-Guzman; Yaw Amoako; Al Artaman; Tadesse Awoke Ayele; Aleksandra Barac; Isabela Bensenor; Adugnaw Berhane; Zulfiqar Bhutta; Jacqueline Castillo-Rivas; Abdulaal Chitheer; Jee-Young Choi; Benjamin Cowie; Lalit Dandona; Rakhi Dandona; Subhojit Dey; Daniel Dicker; Huyen Phuc; Donatus U. Ekwueme; Maysaa El Sayed Zaki; Florian Fischer; Thomas Fürst; Jamie Hancock; Simon I. Hay; Peter Hotez; Sun Ha Jee; Amir Kasaeian; Yousef Khader; Young-Ho Khang; Anil Kumar; Michael Kutz; Heidi Larson; Alan Lopez; Raimundas Lunevicius; Reza Malekzadeh; Colm McAlinden; Toni Meier; Walter Mendoza; Ali Mokdad; Maziar Moradi-Lakeh; Gabriele Nagel; Quyen Nguyen; Grant Nguyen; Felix Ogbo; George Patton; David M. Pereira; Farshad Pourmalek; Mostafa Qorbani; Amir Radfar; Gholamreza Roshandel; Joshua A Salomon; Juan Sanabria; Benn Sartorius; Maheswar Satpathy; Monika Sawhney; Sadaf Sepanlou; Katya Shackelford; Hirbo Shore; Jiandong Sun; Desalegn Tadese Mengistu; Roman Topór-Mądry; Bach Tran; Vasiliy Vlassov; Stein Emil Vollset; Theo Vos; Tolassa Wakayo; Elisabete Weiderpass; Andrea Werdecker; Naohiro Yonemoto; Mustafa Younis; Chuanhua Yu; Zoubida Zaidi; Liguo Zhu; Christopher J. L. Murray; Mohsen Naghavi; Christina Fitzmaurice
Journal:  JAMA Oncol       Date:  2017-12-01       Impact factor: 31.777

View more
  71 in total

Review 1.  Hepatocellular carcinoma and non-alcoholic fatty liver disease.

Authors:  Pegah Golabi; Logan Rhea; Linda Henry; Zobair M Younossi
Journal:  Hepatol Int       Date:  2019-11-07       Impact factor: 6.047

2.  Second hits exacerbate alcohol-related organ damage: an update.

Authors:  Natalia A Osna; Murali Ganesan; Devanshi Seth; Todd A Wyatt; Srivatsan Kidambi; Kusum K Kharbanda
Journal:  Alcohol Alcohol       Date:  2021-01-04       Impact factor: 2.826

3.  Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint.

Authors:  Noreddine Benkerroum
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

4.  ROCK2 disturbs MKP1 expression to promote invasion and metastasis in hepatocellular carcinoma.

Authors:  Yunyan Du; Shan Lu; Jin Ge; Dazhi Long; Chongyu Wen; Shengxing Tan; Leifeng Chen; Wei Zhou
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

5.  Disparities in Presentation at Time of Hepatocellular Carcinoma Diagnosis: A United States Safety-Net Collaborative Study.

Authors:  Joshua P Kronenfeld; Emily L Ryon; David Goldberg; Rachel M Lee; Adam Yopp; Annie Wang; Ann Y Lee; Sommer Luu; Cary Hsu; Eric Silberfein; Maria C Russell; Alan S Livingstone; Nipun B Merchant; Neha Goel
Journal:  Ann Surg Oncol       Date:  2020-09-25       Impact factor: 5.344

6.  A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid.

Authors:  Wei Zhu; Peter F Doubleday; Daniel S Catlin; Pathum M Weerawarna; Arseniy Butrin; Sida Shen; Zdzislaw Wawrzak; Neil L Kelleher; Dali Liu; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2020-03-01       Impact factor: 15.419

7.  Educating Primary Care Providers and Associate Care Providers About Hepatitis C Screening of Baby Boomers: a Multi-practice Study.

Authors:  Bertha E Flores; Andrea A Fernandez; Chen-Pin Wang; Raudel Bobadilla; Ludivina Hernandez; Mamta K Jain; Barbara J Turner
Journal:  J Cancer Educ       Date:  2022-02       Impact factor: 2.037

8.  Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study.

Authors:  Dan-Hong Yang; Wei-Ping Wang; Qiang Zhang; Hong-Ying Pan; Yi-Cheng Huang; Jia-Jie Zhang
Journal:  World J Gastroenterol       Date:  2021-05-07       Impact factor: 5.742

9.  Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1.

Authors:  Jian Pu; Xianjian Wu; Yi Wu; Zesheng Shao; Chunying Luo; Qianli Tang; Jianchu Wang; Huamei Wei; Yuan Lu
Journal:  Aging (Albany NY)       Date:  2021-03-22       Impact factor: 5.682

10.  Down-regulation of small nuclear RNA (snRNA) RNU5E-1 in hepatocellular carcinoma presents with vital clinical significance.

Authors:  Yuan Ding; Zhongquan Sun; Sitong Zhang; Xin Han; Yanjie Li; Qianhui Xu; Liuzhi Zhou; Hao Xu; Yang Bai; Chang Xu; Hao Ding; Yao Ge; Weilin Wang
Journal:  J Gastrointest Oncol       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.